Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
On 1 August 2016, the interest of Marc Dunoyer, a person discharging managerial
responsibilities, in the ordinary shares of AstraZeneca PLC changed as detailed
below.
The change in interest relates to the vesting of awards of shares made in August
2013 under the AstraZeneca Performance Share Plan and the AstraZeneca Restricted
Share Plan.
Following the application of performance measures specified at the time of
grant, Mr Dunoyer has become beneficially entitled to 78% of the shares
originally awarded. In accordance with the plan rules, any unvested part of the
award has immediately and irrevocably lapsed.
After sufficient vested shares were withheld to satisfy certain tax obligations
arising on the vesting, Mr Dunoyer has become beneficially entitled to and has
received 43,730 shares into a personal brokerage account.
For tax purposes, the fair market value of the shares at vest was 5048 pence per
share being the closing price of AstraZeneca ordinary shares on the last trading
day preceding the vesting day.
The attached notification, made in accordance with the requirements of the EU
Market Abuse Regulation, gives further detail.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging
managerial responsibilities / person
closely associated
a) Name Marc Dunoyer
2 Reason for the notification
a) Position/status Chief
Financial
Officer
b) Initial notification /Amendment Initial
notification
3 Details of the issuer, emission
allowance market participant, auction
platform, auctioneer or auction monitor
a) Name AstraZeneca
PLC
b) LEI Not
applicable
4 Details of the transaction(s): section
to be repeated for (i) each type of
instrument; (ii) each type of
transaction; (iii) each date; and (iv)
each place where transactions have been
conducted
a) Description of the financial Ordinary
instrument, type of instrument Shares of
Identification code US$0.25 each
in
AstraZeneca
PLC
GB0009895292
b) Nature of the transaction Acquisition
of Ordinary
Shares
pursuant to
a vesting of
awards under
the
AstraZeneca
Performance
Share Plan
and the
AstraZeneca
Restricted
Share Plan
c) Price(s) and volume(s) Price(s) Volume(s)
5048 43,730
pence
d) Aggregated information - Aggregated Not
volume - Price applicable -
single
transaction
e) Date of the transaction 1 August
2016
f) Place of the transaction London
A C N Kemp
Company Secretary
1 August 2016
Director/PDMR Shareholding
| Source: AstraZeneca PLC